Publications by the researcher in collaboration with JOSE MANUEL RODRIGO GOMEZ (80)

2012

  1. Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy

    NeuroImage, Vol. 61, Núm. 4, pp. 1165-1175

  2. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests

    Hepatology, Vol. 55, Núm. 2, pp. 530-539

2011

  1. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis

    American Journal of Gastroenterology, Vol. 106, Núm. 9, pp. 1629-1637

  2. Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies

    International Journal of Molecular Medicine, Vol. 27, Núm. 1, pp. 111-117

2010

  1. Serum metabolic signature of minimal hepatic encephalopathy by 1H-nuclear magnetic resonance

    Journal of Proteome Research, Vol. 9, Núm. 10, pp. 5180-5187

2009

  1. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy

    Journal of Clinical Gastroenterology, Vol. 43, Núm. 3, pp. 272-279

  2. Unchanged plasma levels of dimethylarginines and nitric oxide in chronic hepatitis C

    Scandinavian Journal of Gastroenterology, Vol. 44, Núm. 2, pp. 224-228

2008

  1. Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects?

    World Journal of Gastroenterology, Vol. 14, Núm. 40, pp. 6171-6179

  2. Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

    Journal of Gastroenterology and Hepatology (Australia), Vol. 23, Núm. 6, pp. 861-866

2007

  1. A single transient episode of hyperammonemia induces long-lasting alterations in protein kinase A

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 292, Núm. 1

  2. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients

    Journal of Molecular Medicine, Vol. 85, Núm. 3, pp. 233-241

2006

  1. Accumulation of symmetric dimethylarginine in hepatorenal syndrome

    Experimental Biology and Medicine, Vol. 231, Núm. 1, pp. 70-75

  2. Changing prevalence, clinical features, and outcome of acute hepatitis in Spain (1982-2003)

    Journal of Gastroenterology and Hepatology (Australia), Vol. 21, Núm. 6, pp. 982-987

2005

  1. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis

    Liver International, Vol. 25, Núm. 4, pp. 787-795

2004

  1. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease

    Neurochemistry International

  2. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis

    Scandinavian Journal of Gastroenterology, Vol. 39, Núm. 11, pp. 1149-1153

  3. Increased protein kinase A regulatory subunit content and cGMP binding in erythrocyte membranes in liver cirrhosis

    Journal of Hepatology, Vol. 40, Núm. 5, pp. 766-773

  4. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis

    Journal of Hepatology, Vol. 41, Núm. 1, pp. 55-59

2003

  1. Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis

    Journal of Clinical Gastroenterology, Vol. 36, Núm. 2, pp. 170-174

  2. Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage

    Journal of Viral Hepatitis, Vol. 10, Núm. 3, pp. 183-188